Troels Jordansen Appointed As Chief Executive Officer of Yaqrit, Replacing Professor Rajiv Jalan

Jan 10, 2025•7 months ago

Position

Chief Executive Officer

Company

Yaqrit

Troels Jordansen

LondonTherapeuticsBiotechnologyHealth Care

Description

Yaqrit, a late-stage biotech and medtech company, announced the appointment of Troels Jordansen as its new Chief Executive Officer. Mr. Jordansen replaces Professor Rajiv Jalan, the company’s Founder and Interim CEO, and is poised to lead the company in several late-stage trials of its products for the treatment of complications associated with advanced liver disease, and to launch a phase 3 study.

Company Information

Company

Yaqrit

Location

London, England, United Kingdom

About

Yaqrit is a clinical-stage company discovering and developing innovative treatments for patients with advanced liver disease at high risk of hospitalization and death. Yaqrit’s pipeline includes novel therapeutics in phase 2 / 3 clinical trials and two medical devices entering registrational trials providing acute and chronic treatments for advanced cirrhosis and acute-on-chronic liver failure, where there is an urgent need for more effective treatments.

Related People

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months